Efficacy and safety of 125I seed implantation combined with thyroid-stimulating hormone suppression therapy in cervical lymph node metastases of differentiated thyroid carcinoma.

Saved in:
Bibliographic Details
Title: Efficacy and safety of 125I seed implantation combined with thyroid-stimulating hormone suppression therapy in cervical lymph node metastases of differentiated thyroid carcinoma.
Authors: Ruan Y; Department of Nuclear Medicine Changde Hospital Xiangya School of Medicine Central South University (The first people's hospital of Changde city), Changde, Hunan, China., Yuan H; Department of Nuclear Medicine Changde Hospital Xiangya School of Medicine Central South University (The first people's hospital of Changde city), Changde, Hunan, China., Zheng F; Department of Nuclear Medicine Changde Hospital Xiangya School of Medicine Central South University (The first people's hospital of Changde city), Changde, Hunan, China., Yang Y; Department of Radiological Physics Technology The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University (Hunan Cancer Hospital), Changsha, Hunan, China., Chen X; Department of Nuclear Medicine Changde Hospital Xiangya School of Medicine Central South University (The first people's hospital of Changde city), Changde, Hunan, China., Xu C; Department of Nuclear Medicine Changde Hospital Xiangya School of Medicine Central South University (The first people's hospital of Changde city), Changde, Hunan, China.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 May 08; Vol. 17, pp. 1747769. Date of Electronic Publication: 2026 May 08 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-2392
DOI:10.3389/fendo.2026.1747769